[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB8909916D0 - Polypeptides - Google Patents

Polypeptides

Info

Publication number
GB8909916D0
GB8909916D0 GB898909916A GB8909916A GB8909916D0 GB 8909916 D0 GB8909916 D0 GB 8909916D0 GB 898909916 A GB898909916 A GB 898909916A GB 8909916 A GB8909916 A GB 8909916A GB 8909916 D0 GB8909916 D0 GB 8909916D0
Authority
GB
United Kingdom
Prior art keywords
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB898909916A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Albumedix Ltd
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Priority to GB898909916A priority Critical patent/GB8909916D0/en
Publication of GB8909916D0 publication Critical patent/GB8909916D0/en
Priority to JP2506978A priority patent/JP2781459B2/en
Priority to EP90907285A priority patent/EP0470165A1/en
Priority to AU55646/90A priority patent/AU630450B2/en
Priority to HU904413A priority patent/HUT61049A/en
Priority to PCT/GB1990/000650 priority patent/WO1990013653A1/en
Priority to CA002015687A priority patent/CA2015687C/en
Priority to IE155490A priority patent/IE67651B1/en
Priority to ZA903237A priority patent/ZA903237B/en
Priority to IL9424390A priority patent/IL94243A/en
Priority to GB9119043A priority patent/GB2246783B/en
Priority to KR1019910701334A priority patent/KR100227167B1/en
Priority to FI915073A priority patent/FI104255B/en
Priority to US08/153,799 priority patent/US5766883A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/31Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB898909916A 1989-04-29 1989-04-29 Polypeptides Pending GB8909916D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GB898909916A GB8909916D0 (en) 1989-04-29 1989-04-29 Polypeptides
JP2506978A JP2781459B2 (en) 1989-04-29 1990-04-26 Fusion protein containing N-terminal fragment of human serum albumin
EP90907285A EP0470165A1 (en) 1989-04-29 1990-04-26 Fusion proteins containing n-terminal fragments of human serum albumin
AU55646/90A AU630450B2 (en) 1989-04-29 1990-04-26 Fusion proteins containing n-terminal fragments of human serum albumin
HU904413A HUT61049A (en) 1989-04-29 1990-04-26 Process for producing polypeptides
PCT/GB1990/000650 WO1990013653A1 (en) 1989-04-29 1990-04-26 Fusion proteins containing n-terminal fragments of human serum albumin
ZA903237A ZA903237B (en) 1989-04-29 1990-04-27 Polypeptides
CA002015687A CA2015687C (en) 1989-04-29 1990-04-27 Human serum albomin fusion polypeptide
IE155490A IE67651B1 (en) 1989-04-29 1990-04-27 Polypeptides
IL9424390A IL94243A (en) 1989-04-29 1990-04-29 Fusion polypeptide and its preparation
GB9119043A GB2246783B (en) 1989-04-29 1991-09-06 Fusion proteins containing n-terminal fragments of human serum albumin
KR1019910701334A KR100227167B1 (en) 1989-04-29 1991-10-14 Fusion protein containing n-terminal fragments of human serum albumin
FI915073A FI104255B (en) 1989-04-29 1991-10-28 Process for Preparation of Fusion Proteins Containing N-Terminal Fragments of Human Serum Albumin
US08/153,799 US5766883A (en) 1989-04-29 1993-11-17 Polypeptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898909916A GB8909916D0 (en) 1989-04-29 1989-04-29 Polypeptides

Publications (1)

Publication Number Publication Date
GB8909916D0 true GB8909916D0 (en) 1989-06-14

Family

ID=10656000

Family Applications (2)

Application Number Title Priority Date Filing Date
GB898909916A Pending GB8909916D0 (en) 1989-04-29 1989-04-29 Polypeptides
GB9119043A Expired - Lifetime GB2246783B (en) 1989-04-29 1991-09-06 Fusion proteins containing n-terminal fragments of human serum albumin

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9119043A Expired - Lifetime GB2246783B (en) 1989-04-29 1991-09-06 Fusion proteins containing n-terminal fragments of human serum albumin

Country Status (12)

Country Link
EP (1) EP0470165A1 (en)
JP (1) JP2781459B2 (en)
KR (1) KR100227167B1 (en)
AU (1) AU630450B2 (en)
CA (1) CA2015687C (en)
FI (1) FI104255B (en)
GB (2) GB8909916D0 (en)
HU (1) HUT61049A (en)
IE (1) IE67651B1 (en)
IL (1) IL94243A (en)
WO (1) WO1990013653A1 (en)
ZA (1) ZA903237B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
FR2686900B1 (en) * 1992-01-31 1995-07-21 Rhone Poulenc Rorer Sa NOVEL POLYPEPTIDES HAVING GRANULOCYTE COLONY STIMULATION ACTIVITY, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2686899B1 (en) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa NOVEL BIOLOGICALLY ACTIVE POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
WO1994016085A2 (en) * 1992-12-30 1994-07-21 Zymogenetics, Inc. Hybrid proteins having cross-linking and tissue-binding activities
GB9408466D0 (en) * 1994-04-27 1994-06-22 Univ Nottingham Cloning and functional expression of neurotoxins
US5543308A (en) * 1994-10-18 1996-08-06 New England Biolabs, Inc. Isolated DNA encoding the FSEI restriction endonuclease and related methods for producing the same
US5877149A (en) 1995-06-07 1999-03-02 Beaulieu; Andre Deepithelialized skin diffusion cell system
US5641483A (en) * 1995-06-07 1997-06-24 Beaulieu; Andre Wound healing formulations containing human plasma fibronectin
MY120425A (en) * 1996-07-26 2005-10-31 Novartis Ag Fusion polypeptides
US6423512B1 (en) 1996-07-26 2002-07-23 Novartis Ag Fusion polypeptides
US5932693A (en) * 1996-12-10 1999-08-03 Washington University Antithrombotic peptides
AU2149899A (en) 1998-01-23 1999-08-09 Novo Nordisk A/S Process for making desired polypeptides in yeast
JP4087563B2 (en) 1998-06-15 2008-05-21 ジーティーシー バイオセラピューティックス インコーポレイテッド Erythropoietin analog-human serum albumin fusion
CA2405701A1 (en) 2000-04-12 2001-10-25 Human Genome Sciences, Inc. Albumin fusion proteins
DE60232083D1 (en) 2001-08-15 2009-06-04 Takara Bio Inc EXPANSION CULTURE PROCEDURE FOR ANTIGEN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
ES2500918T3 (en) 2001-12-21 2014-10-01 Human Genome Sciences, Inc. Albumin and interferon beta fusion proteins
CN102321579A (en) 2002-03-25 2012-01-18 宝生物工程株式会社 The method for preparing cytotoxic lymphocyte
AU2004267313B2 (en) * 2003-08-22 2009-09-24 Takara Bio Inc. Process for producing cytotoxic lymphocytes
US7850970B2 (en) 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
GB0329722D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
WO2006067511A1 (en) 2004-12-23 2006-06-29 Novozymes Delta Limited Gene expression technique
GB0329681D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
EP1816201A1 (en) 2006-02-06 2007-08-08 CSL Behring GmbH Modified coagulation factor VIIa with extended half-life
EP2046367A4 (en) 2006-06-07 2009-11-11 Human Genome Sciences Inc Albumin fusion proteins
CA2657277C (en) 2006-07-13 2015-11-24 Upperton Limited Process for preparing particles of proteinaceous material
CN106986933A (en) 2009-02-11 2017-07-28 阿尔布梅迪克斯医疗公司 Albumin variants and conjugate
JP2013509170A (en) 2009-10-30 2013-03-14 ノボザイムス バイオファーマ デーコー アクティーゼルスカブ Albumin variant
WO2011124718A1 (en) 2010-04-09 2011-10-13 Novozymes A/S Albumin derivatives and variants
KR102103476B1 (en) * 2011-06-24 2020-04-23 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
US20140315817A1 (en) 2011-11-18 2014-10-23 Eleven Biotherapeutics, Inc. Variant serum albumin with improved half-life and other properties
EP3330283A3 (en) 2012-03-16 2018-07-11 Albumedix A/S Albumin variants
EP2917233A1 (en) 2012-11-08 2015-09-16 Novozymes Biopharma DK A/S Albumin variants
EP2968587A2 (en) 2013-03-13 2016-01-20 Bristol-Myers Squibb Company Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto
EP3337816B1 (en) 2015-08-20 2024-02-14 Albumedix Ltd Albumin variants and conjugates
EP3538560A4 (en) * 2016-11-10 2020-06-17 Keros Therapeutics, Inc. Gdnf fusion polypeptides and methods of use thereof
BR112021008200A2 (en) * 2018-10-29 2021-12-14 Spin Therapeutics Llc Compositions and methods for alpha-1-antitrypsin disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE459586B (en) * 1987-09-14 1989-07-17 Mta Szegedi Biolog Koezponti THE STRUCTURES CODING FOR AUTHENTIC HUMAN SERUM ALBUMIN AND PROCEDURES FOR ITS PREPARATION
GB8725529D0 (en) * 1987-10-30 1987-12-02 Delta Biotechnology Ltd Polypeptides

Also Published As

Publication number Publication date
ZA903237B (en) 1991-03-27
CA2015687C (en) 2000-08-29
HU904413D0 (en) 1992-01-28
WO1990013653A1 (en) 1990-11-15
CA2015687A1 (en) 1990-10-29
GB9119043D0 (en) 1991-12-04
FI104255B1 (en) 1999-12-15
GB2246783A (en) 1992-02-12
IE67651B1 (en) 1996-04-17
FI104255B (en) 1999-12-15
KR100227167B1 (en) 1999-10-15
JPH04506598A (en) 1992-11-19
IL94243A0 (en) 1991-01-31
AU630450B2 (en) 1992-10-29
KR920701451A (en) 1992-08-11
AU5564690A (en) 1990-11-29
GB2246783B (en) 1992-10-14
EP0470165A1 (en) 1992-02-12
FI915073A0 (en) 1991-10-28
IE901554L (en) 1990-10-29
JP2781459B2 (en) 1998-07-30
IL94243A (en) 1995-10-31
HUT61049A (en) 1992-11-30

Similar Documents

Publication Publication Date Title
ZA903237B (en) Polypeptides
IL86700A0 (en) Polypeptides
EP0315367A3 (en) Polypeptides
ZA901737B (en) Peptides
GB2206352B (en) Polypeptides
GB8920357D0 (en) Peptides
GB8905606D0 (en) Peptides
IE893163L (en) Polypeptides
IE892797L (en) Polypeptides
IE892132L (en) Polypeptides
IE891583L (en) Polypeptides
GB8924717D0 (en) Polypeptides
GB8913349D0 (en) Polypeptides
IE881947L (en) Polypeptides
IE883022L (en) Polypeptides
IE883303L (en) Polypeptides
GB8907660D0 (en) Polypeptide
IE891125L (en) Preparing polypeptides
IE892648L (en) Synthetic polypeptides
GB8803364D0 (en) Modified polypeptides
IE891133L (en) Peptides
GB8914943D0 (en) Peptides
IE891330L (en) Peptides
IE891528L (en) Peptides
IE892197L (en) Peptides